WealthPlan Investment Management »

Immunitybio shares owned by WealthPlan Investment Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by WealthPlan Investment Management from 13F filings

Historical chart of WealthPlan Investment Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by WealthPlan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by WealthPlan Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $27k 14k 1.98

More positions owned by WealthPlan Investment Management

Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Ea Series Trust Bufferlabs Us Eq (BFLB)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Spdr Series Trust State Street Spd (BIL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr Series Trust State Street Spd (SPAB)
Ishares Tr S&p 500 Val Etf (IVE)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)

View all positions for WealthPlan Investment Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Jane Street
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Woodline Partners
AlphaCore Capital
Two Sigma Investments
Charles Schwab Investment Management
Barclays
Tang Capital Management
Northern Trust
Citadel Advisors

View all funds holding Immunitybio